You just read:

Late-Breaking Abstract Reporting SRA737 Preclinical Activity in CCNE1-Driven and PARPi-Resistant Cancers Accepted for AACR 2018 Annual Meeting

News provided by

Sierra Oncology

Mar 14, 2018, 16:51 ET